Midatech Pharma’s stock (NASDAQ: MTP) suddenly soars 172% after announcing its participation in the Q-Sphera platform with a European affiliate of a global pharmaceutical company. On Monday MTP price was $1.70 that served major stockholders as a trampoline to earn significant margin within hours.
Since May 19th MTP has been facing a flat price near $1.60 without indication of a future blast. The stock is rising now purely on speculation related to collaboration with European regional pharmaceutical manufacturers.
Soon, MTP may fall to the previous price near $2 minimum unless good news arrives in investor relations press release source. For short term goals pursuing traders MTP is the perfect choice to possibly burn little funds that would not create worries in planning the portfolio.